132 related articles for article (PubMed ID: 3474453)
21. A comparison of the platinum analogues in bladder cancer cell lines.
Powles T; Perry J; Shamash J; Liu W; Oliver T; Joel S
Urol Int; 2007; 79(1):67-72. PubMed ID: 17627172
[TBL] [Abstract][Full Text] [Related]
22. Response to doxorubicin of cultured normal and cancerous human mammary epithelial cells.
Smith HS; Lippman ME; Hiller AJ; Stampfer MR; Hackett AJ
J Natl Cancer Inst; 1985 Feb; 74(2):341-7. PubMed ID: 3856048
[TBL] [Abstract][Full Text] [Related]
23. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
24. Prediction of human tumor cell chemosensitivity using the sister chromatid exchange assay.
Deen DF; Kendall LE; Marton LJ; Tofilon PJ
Cancer Res; 1986 Apr; 46(4 Pt 1):1599-602. PubMed ID: 3948148
[TBL] [Abstract][Full Text] [Related]
25. [Adriamycin and mitomycin dose-dependently downregulate X-kinked inhibitor of apoptosis protein in human bladder cancer cells].
Yin ZF; Li M; Lai YQ; Yuan YM; Liu G; Chen L; Gan L; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(25):1774-7. PubMed ID: 17054846
[TBL] [Abstract][Full Text] [Related]
26. Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities.
Byun SS; Kim SW; Choi H; Lee C; Lee E
BJU Int; 2005 May; 95(7):1086-90. PubMed ID: 15839938
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells.
Kotoh S; Naito S; Yokomizo A; Kumazawa J; Asakuno K; Kohno K; Kuwano M
Cancer Res; 1994 Jun; 54(12):3248-52. PubMed ID: 8205547
[TBL] [Abstract][Full Text] [Related]
28. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T
J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.
Hadaschik BA; ter Borg MG; Jackson J; Sowery RD; So AI; Burt HM; Gleave ME
BJU Int; 2008 Jun; 101(11):1347-55. PubMed ID: 18384637
[TBL] [Abstract][Full Text] [Related]
30. [An in vitro chemosensitivity study using human tumor clonogenic assay in urologic malignancies].
Naito K; Hisazumi H; Asari T; Kobashi K; Amano T; Uchibayashi T
Hinyokika Kiyo; 1986 Dec; 32(12):1959-66. PubMed ID: 3825833
[TBL] [Abstract][Full Text] [Related]
31. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
Tyagi AK; Agarwal C; Chan DC; Agarwal R
Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
[TBL] [Abstract][Full Text] [Related]
32. Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells.
Mizutani Y; Yoshida O; Miki T; Bonavida B
Clin Cancer Res; 1999 Sep; 5(9):2605-12. PubMed ID: 10499639
[TBL] [Abstract][Full Text] [Related]
33. Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo.
Wirger A; Perabo FG; Burgemeister S; Haase L; Schmidt DH; Doehn C; Mueller SC; Jocham D
Anticancer Res; 2005; 25(6B):4341-7. PubMed ID: 16309238
[TBL] [Abstract][Full Text] [Related]
34. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
35. Comparison of in vitro methods for assessing cytotoxic activity against two pancreatic adenocarcinoma cell lines.
Chang BK
Cancer Res; 1983 Jul; 43(7):3147-9. PubMed ID: 6850624
[TBL] [Abstract][Full Text] [Related]
36. [The chemotherapy of urologic neoplasms].
Cavalli F
Helv Chir Acta; 1978 Jul; 45(3):223-32. PubMed ID: 359509
[TBL] [Abstract][Full Text] [Related]
37. Establishment of doxorubicin-resistant human bladder cancer cell line (BUI-87/ADMR) and its mechanism of multidrug resistance.
Guo H; Lu G; Xiong X; Dong J; Liu S
Chin Med J (Engl); 1997 Mar; 110(3):167-72. PubMed ID: 9594332
[TBL] [Abstract][Full Text] [Related]
38. Direct effects of chemotherapeutic agents on rat prostate tumor clonogenic cells.
Geldof AA; Rao BR; de Voogt HJ
Anticancer Res; 1986; 6(4):837-40. PubMed ID: 3752961
[TBL] [Abstract][Full Text] [Related]
39. Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation.
Chlebowski RT; Dietrich M; Akman S; Block JB
Cancer Treat Rep; 1985 May; 69(5):527-32. PubMed ID: 4005875
[TBL] [Abstract][Full Text] [Related]
40. Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs.
Cinatl J; Cinatl J; Kotchetkov R; Matousek J; Woodcock BG; Koehl U; Vogel JU; Kornhuber B; Schwabe D
Anticancer Res; 2000; 20(2A):853-9. PubMed ID: 10810366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
